SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016610
Filing Date
2022-11-07
Accepted
2022-11-07 16:07:57
Documents
73
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20220930x10q.htm   iXBRL 10-Q 1656912
2 EX-31.1 ocul-20220930xex31d1.htm EX-31.1 12012
3 EX-31.2 ocul-20220930xex31d2.htm EX-31.2 8452
4 EX-32.1 ocul-20220930xex32d1.htm EX-32.1 4999
5 EX-32.2 ocul-20220930xex32d2.htm EX-32.2 4980
  Complete submission text file 0001558370-22-016610.txt   5957943

Data Files

Seq Description Document Type Size
6 EX-101.SCH ocul-20220930.xsd EX-101.SCH 40685
7 EX-101.CAL ocul-20220930_cal.xml EX-101.CAL 49916
8 EX-101.DEF ocul-20220930_def.xml EX-101.DEF 159787
9 EX-101.LAB ocul-20220930_lab.xml EX-101.LAB 307613
10 EX-101.PRE ocul-20220930_pre.xml EX-101.PRE 266971
67 EXTRACTED XBRL INSTANCE DOCUMENT ocul-20220930x10q_htm.xml XML 987578
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 221365463
SIC: 2834 Pharmaceutical Preparations